HM Payson & Co’s Genmab GMAB Stock Holding History

HM Payson & Co’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-27	Closed	-$1K	–	1113
2021 Q3	$1K	Hold	27	–	–	﹤0.01%	1043
2021 Q2	$1K	Hold	27	–	–	﹤0.01%	1048
2021 Q1	$1K	Hold	27	–	–	﹤0.01%	1091
2020 Q4	$1K	Buy	+27	New	+$1.01K	﹤0.01%	1051

Other funds holding GMAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HM Payson & Co's GMAB Position: Q4 2021 in Review

HM Payson & Co sold out of Genmab (GMAB) in Q4 2021, closing a stake of 27 shares — an estimated $1K sold.

HM Payson & Co first reported a position in GMAB in Q4 2020 and held it in 4 quarters. The position peaked at $1K in Q3 2021. 211 funds tracked by Wall St. Rank hold GMAB as of Q4 2021.

HM Payson & Co reported no remaining Genmab position as of Q4 2021 after selling out during the quarter.
HM Payson & Co sold 27 Genmab shares in Q4 2021, an estimated $1K.
HM Payson & Co first reported a position in Genmab in Q4 2020 and held it in 4 quarters.
HM Payson & Co's Genmab position peaked at $1K in Q3 2021.
211 funds tracked by Wall St. Rank held Genmab as of Q4 2021.

Based on HM Payson & Co's 13F filing for Q4 2021, filed 15 Feb 2022.